Uromedical Center s.r.o.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Prostate cancer4 trials

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Aragon Pharmaceuticals, Inc.1 trial
• Astellas Pharma Global Development, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

  NCT03767244· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

  NCT03748641· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

  NCT02960022· Phase 2· Astellas Pharma Global Development, Inc.· Source

• Active, not recruiting

  An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

  NCT02531516· Phase 3· Aragon Pharmaceuticals, Inc.· Source